Dr Nick West (Royal Papworth Hospital, Cambridge, UK) discusses The ABSORB UK registry - Final three-year outcomes of patients receiving everolimus-eluting BRS in real-world practice.
1. What is the ABSORB UK registry and what data are you presenting at EuroPCR 2019?
2. What were the major findings from ABSORB UK and does the three-year data tell us anything different?
3. As a result of this data, other registries and RCTs what is needed to restore confidence in the BRS technology, and how can this be achieved?
4. In your opinion, does BRS technology have a future in clinical practice?
Videogarpher: Mike Knight Filmed on site at Euro PCR 2019 by Radcliffe Cardiology